Novel compounds target 5-HT2A receptor to treat depression, anxiety, substance abuse, and headaches, suggesting a new therapeutic avenue.
High Resolution Image Download MS PowerPoint Slide Provided herein are novel 6,5-bicyclic compounds as 5-HT2A receptor agonists, pharmaceutical compositions, use of such compounds in treating depression, anxiety, substance abuse, and headaches, and processes for preparing such compounds.
No takes yet. Share an insight, caveat, or question.
Sabnis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: